Sudden Deafness Treatment Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

March 31, 2011

Conditions
Sudden Deafness
Interventions
DRUG

prednisone

Oral, 19 days

DRUG

methylprednisolone sodium succinate

Four intratympanic injections delivered to the middle ear over 2 weeks

Trial Locations (14)

10003

New York Eye and Ear Infirmary, New York

10016

New York University School of Medicine, New York

32610

University of Florida, College of Medicine, Gainesville

48334

Michigan Ear Institute, Farmington Hills

63110

Washington University School of Medicine, St Louis

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

90057

House Ear Institute, Los Angeles

92103-8895

University of California San Diego, San Diego

52242-1078

University of Iowa, Iowa City

21287-0910

Johns Hopkins University, Baltimore

02114

Massachusetts Eye & Ear Infirmary, Boston

01655

University of Massachusetts Medical School, Worcester

48109-0312

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Massachusetts Eye and Ear Infirmary

OTHER

NCT00097448 - Sudden Deafness Treatment Trial | Biotech Hunter | Biotech Hunter